Smart Fertility Tracker Wearable Market Global Report 2026

The smart fertility tracker wearable market size has grown rapidly in recent years. It will grow from $1.19 billion in 2025 to $1.38 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increasing awareness of reproductive health management, growing adoption of wearable health-monitoring devices, rising demand for fertility planning solutions, increasing utilization of mobile health applications, and growing emphasis on personalized healthcare approaches.

The smart fertility tracker wearable market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing integration of advanced fertility prediction technologies, growing adoption of connected women's health platforms, rising demand for home-based fertility monitoring solutions, increasing investment in digital reproductive health technologies, and rising consumer preference for personalized health insights. Major trends in the forecast period include growing adoption of personalized fertility monitoring solutions, increasing demand for non-invasive fertility tracking devices, rising preference for connected women's health wearables, increasing emphasis on reproductive health awareness and planning, and growing demand for continuous monitoring of physiological health indicators.

The increasing prevalence of infertility is expected to propel the growth of the smart fertility tracker wearable market going forward. Infertility is a medical condition defined by the inability to achieve pregnancy after 12 months of regular unprotected intercourse, or physical difficulties in conceiving or carrying a pregnancy to live birth. The prevalence of infertility is increasing due to delayed childbearing trends, as more individuals postpone family planning until later reproductive years, when age-related declines in egg quality, ovarian reserve, and sperm parameters substantially reduce the likelihood of conception. Smart fertility tracker wearables support infertility management by continuously monitoring key fertility biomarkers, improving ovulation prediction accuracy, providing personalized reproductive health insights, and enabling informed conception planning. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, experience infertility, emphasizing the urgent need to improve access to affordable, high-quality fertility care for those affected. Therefore, the increasing prevalence of infertility is driving the growth of the smart fertility tracker wearable market.

Leading companies operating in the smart fertility tracker wearable market are focusing on developing innovative solutions, such as mobile-integrated fertility monitoring systems, to enhance real-time reproductive health tracking, improve prediction accuracy, and enable personalized fertility insights for users. Mobile-integrated fertility monitoring systems are advanced wearable-enabled reproductive health platforms that combine biosensors, smartphone connectivity, artificial intelligence, and cloud-based analytics to provide real-time fertility insights and menstrual cycle predictions. For example, in March 2026, Garmin Ltd., a Switzerland-based wearable technology company, launched an official integration with Natural Cycles for compatible Garmin smartwatches, including the fēnix 8, Forerunner 570, Forerunner 970, Venu 4, and Venu X1 series. This innovative fertility tracking integration enables users to monitor overnight skin temperature directly through Garmin smartwatches, with automatic synchronization to the Natural Cycles app for fertility and reproductive health insights. The solution utilizes temperature-based fertility algorithms, FDA-cleared digital birth control technology, and continuous wearable sensing capabilities to deliver personalized fertility status monitoring. The integration enhances user convenience by eliminating manual temperature tracking while supporting non-hormonal birth control and pregnancy planning applications. It also strengthens the role of AI-powered wearable ecosystems in digital women’s healthcare and connected reproductive wellness management.

In August 2025, Ultrahuman Healthcare Private Limited, an India-based health technology company, acquired viO HealthTech for an undisclosed amount. Through this acquisition, Ultrahuman intends to strengthen its women’s health offerings by incorporating advanced fertility intelligence and ovulation monitoring capabilities into its existing metabolic health ecosystem, enabling the delivery of more comprehensive and cycle-aware health insights. viO HealthTech is a US-based company that provides wearable smart fertility tracking devices and technologies for reproductive health monitoring.

Major companies operating in the smart fertility tracker wearable market are Apple Inc., Samsung Electronics Co Ltd., Whoop Inc., Oura Health Oy, Natural Cycles Nordic AB, Bellabeat Inc., Ultrahuman Healthcare Ltd., RingConn Inc., Ava AG, Femometer Inc., Tempdrop LLC, viO HealthTech, Movano Inc., Raiing Medical Company, Circular Health, YONO Health Inc., Prima-Temp Inc.

North America was the dominant region in the smart fertility tracker wearable market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the smart fertility tracker wearable market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart fertility tracker wearable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.